LOS ANGELES , May 8, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Compass Diversified ("Compass" or "the Company") (NYSE: CODI) for viol
NEW YORK, NY / ACCESS Newswire / May 8, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Compass Diversified ("Compass Diversified") (NYSE:CODI) concerning possible
Revenue in Q1 Grew 28.7% YoY and Organic Revenue Grew 14.6% YoY  Quarterly Market Share Grew 125bps YoY to a Record 6.0%; Organic Share Was Up 82bps Operating Cash Flow Grew 169% YoY to a Record $23.
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Compass Diversified Holdings (
SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP is investigating whether Compass Diversified (NYSE: CODI) or any of its executive officers or others violated securities laws by misrepresenting or fai
NEW YORK CITY, NY / ACCESS Newswire / May 8, 2025 / Wolf Popper LLP is investigating potential claims on behalf of purchasers of Compass Diversified Holdings ("Compass") common stock (NYSE:CODI). Comp
PHILADELPHIA, PA / ACCESS Newswire / May 8, 2025 / Kehoe Law Firm, P.C. is investigating potential securities fraud claims on behalf of investors of Compass Group Diversified Holdings LLC d/b/a Compas
Tovecimig (DLL4 x VEGF-A bispecific antibody) met the primary endpoint in the ongoing randomized Phase 2/3 Study in patients with biliary tract cancer (BTC). Achieved a 17.1% overall response rate (OR
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
OVERLAND PARK, Kan.--(BUSINESS WIRE)--Compass Minerals (NYSE: CMP), a leading global provider of essential minerals, today reported fiscal 2025 second-quarter results. Unless otherwise noted, it shoul
The Company Intends to Delay Quarterly Earnings and Filing of 2025 Q1 Form 10-Q The Company Intends to Delay Quarterly Earnings and Filing of 2025 Q1 Form 10-Q
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Compass (COMP) could be a great choice. It is one of the several stocks that passed
BOSTON, May 06, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, tod
Compass (COMP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NEW YORK , April 30, 2025 /PRNewswire/ -- Compass, Inc. (NYSE: COMP) ("Compass"), a leading tech-enabled real estate services company that includes the largest residential real estate brokerage in the
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE